nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—AR—duct of salivary gland—head and neck cancer	0.101	0.32	CbGeAlD
Danazol—CCL2—exocrine gland—head and neck cancer	0.0215	0.068	CbGeAlD
Danazol—CCL2—mouth—head and neck cancer	0.0161	0.0509	CbGeAlD
Danazol—CCL2—neck—head and neck cancer	0.0137	0.0435	CbGeAlD
Danazol—CCL2—parotid gland—head and neck cancer	0.0112	0.0354	CbGeAlD
Danazol—CCL2—connective tissue—head and neck cancer	0.00985	0.0312	CbGeAlD
Danazol—CCL2—epithelium—head and neck cancer	0.00935	0.0296	CbGeAlD
Danazol—CCL2—trachea—head and neck cancer	0.00827	0.0262	CbGeAlD
Danazol—SHBG—neck—head and neck cancer	0.00802	0.0254	CbGeAlD
Danazol—GNRHR—head—head and neck cancer	0.00743	0.0235	CbGeAlD
Danazol—CCL2—lymphoid tissue—head and neck cancer	0.0072	0.0228	CbGeAlD
Danazol—CCL2—thyroid gland—head and neck cancer	0.00654	0.0207	CbGeAlD
Danazol—CCL2—head—head and neck cancer	0.0058	0.0184	CbGeAlD
Danazol—SHBG—connective tissue—head and neck cancer	0.00575	0.0182	CbGeAlD
Danazol—ESR1—neck—head and neck cancer	0.00565	0.0179	CbGeAlD
Danazol—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00546	0.0301	CcSEcCtD
Danazol—PGR—connective tissue—head and neck cancer	0.00518	0.0164	CbGeAlD
Danazol—Interstitial pneumonia—Docetaxel—head and neck cancer	0.00516	0.0285	CcSEcCtD
Danazol—PGR—epithelium—head and neck cancer	0.00492	0.0156	CbGeAlD
Danazol—CYP19A1—connective tissue—head and neck cancer	0.00466	0.0147	CbGeAlD
Danazol—AR—connective tissue—head and neck cancer	0.00412	0.0131	CbGeAlD
Danazol—CCL2—lymph node—head and neck cancer	0.00406	0.0129	CbGeAlD
Danazol—ESR1—connective tissue—head and neck cancer	0.00405	0.0128	CbGeAlD
Danazol—AR—epithelium—head and neck cancer	0.00392	0.0124	CbGeAlD
Danazol—ESR1—epithelium—head and neck cancer	0.00384	0.0122	CbGeAlD
Danazol—SHBG—thyroid gland—head and neck cancer	0.00382	0.0121	CbGeAlD
Danazol—PGR—lymphoid tissue—head and neck cancer	0.00379	0.012	CbGeAlD
Danazol—Leukocytosis—Fluorouracil—head and neck cancer	0.00367	0.0203	CcSEcCtD
Danazol—Interstitial lung disease—Docetaxel—head and neck cancer	0.00352	0.0194	CcSEcCtD
Danazol—Throat sore—Docetaxel—head and neck cancer	0.00346	0.0191	CcSEcCtD
Danazol—PGR—thyroid gland—head and neck cancer	0.00344	0.0109	CbGeAlD
Danazol—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.00343	0.0189	CcSEcCtD
Danazol—CYP19A1—thyroid gland—head and neck cancer	0.00309	0.00979	CbGeAlD
Danazol—PGR—head—head and neck cancer	0.00305	0.00966	CbGeAlD
Danazol—AR—lymphoid tissue—head and neck cancer	0.00302	0.00955	CbGeAlD
Danazol—ESR1—lymphoid tissue—head and neck cancer	0.00296	0.00937	CbGeAlD
Danazol—Pancreatitis—Hydroxyurea—head and neck cancer	0.00295	0.0163	CcSEcCtD
Danazol—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0029	0.016	CcSEcCtD
Danazol—Myocardial infarction—Vinblastine—head and neck cancer	0.00288	0.0159	CcSEcCtD
Danazol—Photosensitivity—Fluorouracil—head and neck cancer	0.00285	0.0158	CcSEcCtD
Danazol—Amenorrhoea—Docetaxel—head and neck cancer	0.00284	0.0157	CcSEcCtD
Danazol—CYP19A1—head—head and neck cancer	0.00275	0.00869	CbGeAlD
Danazol—Oropharyngeal pain—Docetaxel—head and neck cancer	0.00274	0.0151	CcSEcCtD
Danazol—AR—thyroid gland—head and neck cancer	0.00274	0.00867	CbGeAlD
Danazol—Weight increased—Hydroxyurea—head and neck cancer	0.00274	0.0151	CcSEcCtD
Danazol—ESR1—thyroid gland—head and neck cancer	0.00269	0.00851	CbGeAlD
Danazol—Haemoglobin—Vinblastine—head and neck cancer	0.00265	0.0147	CcSEcCtD
Danazol—Haemorrhage—Vinblastine—head and neck cancer	0.00264	0.0146	CcSEcCtD
Danazol—AR—head—head and neck cancer	0.00243	0.00769	CbGeAlD
Danazol—Haemoglobin—Hydroxyurea—head and neck cancer	0.00242	0.0134	CcSEcCtD
Danazol—Haemorrhage—Hydroxyurea—head and neck cancer	0.00241	0.0133	CcSEcCtD
Danazol—Irritability—Fluorouracil—head and neck cancer	0.00239	0.0132	CcSEcCtD
Danazol—ESR1—head—head and neck cancer	0.00239	0.00755	CbGeAlD
Danazol—Fluid retention—Docetaxel—head and neck cancer	0.00237	0.0131	CcSEcCtD
Danazol—Alopecia—Vinblastine—head and neck cancer	0.00233	0.0129	CcSEcCtD
Danazol—Chills—Hydroxyurea—head and neck cancer	0.00216	0.0119	CcSEcCtD
Danazol—Eosinophilia—Fluorouracil—head and neck cancer	0.00214	0.0118	CcSEcCtD
Danazol—PGR—lymph node—head and neck cancer	0.00214	0.00676	CbGeAlD
Danazol—Alopecia—Hydroxyurea—head and neck cancer	0.00213	0.0118	CcSEcCtD
Danazol—Vertigo—Vinblastine—head and neck cancer	0.00207	0.0114	CcSEcCtD
Danazol—Leukopenia—Vinblastine—head and neck cancer	0.00206	0.0114	CcSEcCtD
Danazol—Convulsion—Vinblastine—head and neck cancer	0.00199	0.011	CcSEcCtD
Danazol—Hypertension—Vinblastine—head and neck cancer	0.00198	0.011	CcSEcCtD
Danazol—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00198	0.0109	CcSEcCtD
Danazol—CYP19A1—lymph node—head and neck cancer	0.00192	0.00608	CbGeAlD
Danazol—Visual disturbance—Docetaxel—head and neck cancer	0.00191	0.0105	CcSEcCtD
Danazol—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.0019	0.0105	CcSEcCtD
Danazol—Myocardial infarction—Fluorouracil—head and neck cancer	0.00189	0.0105	CcSEcCtD
Danazol—Leukopenia—Hydroxyurea—head and neck cancer	0.00188	0.0104	CcSEcCtD
Danazol—Thrombocytopenia—Vinblastine—head and neck cancer	0.00184	0.0101	CcSEcCtD
Danazol—Convulsion—Hydroxyurea—head and neck cancer	0.00182	0.01	CcSEcCtD
Danazol—Migraine—Docetaxel—head and neck cancer	0.00178	0.00983	CcSEcCtD
Danazol—Haemoglobin—Fluorouracil—head and neck cancer	0.00174	0.00962	CcSEcCtD
Danazol—Haemorrhage—Fluorouracil—head and neck cancer	0.00173	0.00957	CcSEcCtD
Danazol—Oedema—Hydroxyurea—head and neck cancer	0.00171	0.00945	CcSEcCtD
Danazol—AR—lymph node—head and neck cancer	0.0017	0.00539	CbGeAlD
Danazol—Paraesthesia—Vinblastine—head and neck cancer	0.00168	0.0093	CcSEcCtD
Danazol—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00168	0.00925	CcSEcCtD
Danazol—ESR1—lymph node—head and neck cancer	0.00167	0.00529	CbGeAlD
Danazol—Abdominal pain upper—Docetaxel—head and neck cancer	0.00165	0.00912	CcSEcCtD
Danazol—Cramp muscle—Docetaxel—head and neck cancer	0.00163	0.00899	CcSEcCtD
Danazol—Constipation—Vinblastine—head and neck cancer	0.0016	0.00886	CcSEcCtD
Danazol—Alopecia—Fluorouracil—head and neck cancer	0.00153	0.00846	CcSEcCtD
Danazol—Dyspepsia—Hydroxyurea—head and neck cancer	0.00151	0.00832	CcSEcCtD
Danazol—Fatigue—Hydroxyurea—head and neck cancer	0.00148	0.00815	CcSEcCtD
Danazol—Constipation—Hydroxyurea—head and neck cancer	0.00146	0.00808	CcSEcCtD
Danazol—Weight increased—Docetaxel—head and neck cancer	0.00142	0.00786	CcSEcCtD
Danazol—Vision blurred—Fluorouracil—head and neck cancer	0.00142	0.00785	CcSEcCtD
Danazol—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.00138	0.00763	CcSEcCtD
Danazol—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00137	0.00759	CcSEcCtD
Danazol—Myocardial infarction—Docetaxel—head and neck cancer	0.00137	0.00754	CcSEcCtD
Danazol—Jaundice—Docetaxel—head and neck cancer	0.00136	0.0075	CcSEcCtD
Danazol—Body temperature increased—Hydroxyurea—head and neck cancer	0.00135	0.00747	CcSEcCtD
Danazol—Leukopenia—Fluorouracil—head and neck cancer	0.00135	0.00746	CcSEcCtD
Danazol—Asthenia—Vinblastine—head and neck cancer	0.00135	0.00743	CcSEcCtD
Danazol—Convulsion—Fluorouracil—head and neck cancer	0.00131	0.00722	CcSEcCtD
Danazol—Haemoglobin—Docetaxel—head and neck cancer	0.00126	0.00694	CcSEcCtD
Danazol—Haemorrhage—Docetaxel—head and neck cancer	0.00125	0.00691	CcSEcCtD
Danazol—Dizziness—Vinblastine—head and neck cancer	0.00124	0.00685	CcSEcCtD
Danazol—Oedema—Fluorouracil—head and neck cancer	0.00123	0.0068	CcSEcCtD
Danazol—Asthenia—Hydroxyurea—head and neck cancer	0.00123	0.00678	CcSEcCtD
Danazol—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00121	0.00666	CcSEcCtD
Danazol—Visual impairment—Docetaxel—head and neck cancer	0.00121	0.00666	CcSEcCtD
Danazol—Tachycardia—Fluorouracil—head and neck cancer	0.0012	0.00664	CcSEcCtD
Danazol—Vomiting—Vinblastine—head and neck cancer	0.00119	0.00659	CcSEcCtD
Danazol—Erythema multiforme—Docetaxel—head and neck cancer	0.00118	0.00653	CcSEcCtD
Danazol—Headache—Vinblastine—head and neck cancer	0.00118	0.00649	CcSEcCtD
Danazol—Flushing—Docetaxel—head and neck cancer	0.00116	0.00641	CcSEcCtD
Danazol—Dizziness—Hydroxyurea—head and neck cancer	0.00113	0.00625	CcSEcCtD
Danazol—Chills—Docetaxel—head and neck cancer	0.00112	0.0062	CcSEcCtD
Danazol—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00112	0.0062	CcSEcCtD
Danazol—Nausea—Vinblastine—head and neck cancer	0.00111	0.00615	CcSEcCtD
Danazol—Paraesthesia—Fluorouracil—head and neck cancer	0.00111	0.00611	CcSEcCtD
Danazol—Alopecia—Docetaxel—head and neck cancer	0.00111	0.00611	CcSEcCtD
Danazol—Vomiting—Hydroxyurea—head and neck cancer	0.00109	0.00601	CcSEcCtD
Danazol—Dyspepsia—Fluorouracil—head and neck cancer	0.00108	0.00599	CcSEcCtD
Danazol—Rash—Hydroxyurea—head and neck cancer	0.00108	0.00596	CcSEcCtD
Danazol—Dermatitis—Hydroxyurea—head and neck cancer	0.00108	0.00595	CcSEcCtD
Danazol—Headache—Hydroxyurea—head and neck cancer	0.00107	0.00592	CcSEcCtD
Danazol—Back pain—Docetaxel—head and neck cancer	0.00105	0.00582	CcSEcCtD
Danazol—Muscle spasms—Docetaxel—head and neck cancer	0.00105	0.00578	CcSEcCtD
Danazol—Nausea—Hydroxyurea—head and neck cancer	0.00102	0.00561	CcSEcCtD
Danazol—Urticaria—Fluorouracil—head and neck cancer	0.000978	0.0054	CcSEcCtD
Danazol—Syncope—Docetaxel—head and neck cancer	0.000977	0.00539	CcSEcCtD
Danazol—Leukopenia—Docetaxel—head and neck cancer	0.000975	0.00538	CcSEcCtD
Danazol—Body temperature increased—Fluorouracil—head and neck cancer	0.000974	0.00538	CcSEcCtD
Danazol—Palpitations—Docetaxel—head and neck cancer	0.000963	0.00532	CcSEcCtD
Danazol—Loss of consciousness—Docetaxel—head and neck cancer	0.000957	0.00529	CcSEcCtD
Danazol—Convulsion—Docetaxel—head and neck cancer	0.000944	0.00521	CcSEcCtD
Danazol—Hypertension—Docetaxel—head and neck cancer	0.00094	0.00519	CcSEcCtD
Danazol—Arthralgia—Docetaxel—head and neck cancer	0.000927	0.00512	CcSEcCtD
Danazol—Oedema—Docetaxel—head and neck cancer	0.000889	0.00491	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—CCND1—head and neck cancer	0.000886	0.00176	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	0.000876	0.00174	CbGpPWpGaD
Danazol—Shock—Docetaxel—head and neck cancer	0.000875	0.00483	CcSEcCtD
Danazol—Pruritus—Fluorouracil—head and neck cancer	0.000871	0.00481	CcSEcCtD
Danazol—Thrombocytopenia—Docetaxel—head and neck cancer	0.00087	0.00481	CcSEcCtD
Danazol—Tachycardia—Docetaxel—head and neck cancer	0.000868	0.00479	CcSEcCtD
Danazol—ESR1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000865	0.00172	CbGpPWpGaD
Danazol—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000864	0.00172	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—TP53—head and neck cancer	0.000842	0.00167	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—head and neck cancer	0.000836	0.00166	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000835	0.00166	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—KISS1—head and neck cancer	0.000832	0.00166	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000827	0.00164	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000825	0.00164	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—CCND1—head and neck cancer	0.000819	0.00163	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—MAPK3—head and neck cancer	0.000818	0.00163	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000815	0.00162	CbGpPWpGaD
Danazol—Dizziness—Fluorouracil—head and neck cancer	0.000815	0.0045	CcSEcCtD
Danazol—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.00081	0.00447	CcSEcCtD
Danazol—AR—Androgen receptor signaling pathway—STAT3—head and neck cancer	0.0008	0.00159	CbGpPWpGaD
Danazol—Paraesthesia—Docetaxel—head and neck cancer	0.000798	0.00441	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.000786	0.00156	CbGpPWpGaD
Danazol—Vomiting—Fluorouracil—head and neck cancer	0.000783	0.00432	CcSEcCtD
Danazol—Dyspepsia—Docetaxel—head and neck cancer	0.000783	0.00432	CcSEcCtD
Danazol—ESR1—ATF-2 transcription factor network—MAPK1—head and neck cancer	0.000779	0.00155	CbGpPWpGaD
Danazol—Rash—Fluorouracil—head and neck cancer	0.000777	0.00429	CcSEcCtD
Danazol—Dermatitis—Fluorouracil—head and neck cancer	0.000776	0.00428	CcSEcCtD
Danazol—Headache—Fluorouracil—head and neck cancer	0.000772	0.00426	CcSEcCtD
Danazol—CYP19A1—Metabolism—UROD—head and neck cancer	0.000771	0.00153	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.00077	0.00153	CbGpPWpGaD
Danazol—Fatigue—Docetaxel—head and neck cancer	0.000766	0.00423	CcSEcCtD
Danazol—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.000765	0.00152	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000763	0.00152	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—KISS1—head and neck cancer	0.000761	0.00151	CbGpPWpGaD
Danazol—Constipation—Docetaxel—head and neck cancer	0.00076	0.0042	CcSEcCtD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.000748	0.00149	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.000747	0.00149	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—head and neck cancer	0.000738	0.00147	CbGpPWpGaD
Danazol—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000735	0.00146	CbGpPWpGaD
Danazol—Nausea—Fluorouracil—head and neck cancer	0.000732	0.00404	CcSEcCtD
Danazol—ESR1—Regulation of Telomerase—MAPK3—head and neck cancer	0.00073	0.00145	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—EGFR—head and neck cancer	0.000727	0.00145	CbGpPWpGaD
Danazol—GNRHR—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.000725	0.00144	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000709	0.00141	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000708	0.00141	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—STAT3—head and neck cancer	0.000707	0.00141	CbGpPWpGaD
Danazol—Body temperature increased—Docetaxel—head and neck cancer	0.000703	0.00388	CcSEcCtD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000701	0.00139	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—RARB—head and neck cancer	0.0007	0.00139	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—AKT1—head and neck cancer	0.000698	0.00139	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—MAPK1—head and neck cancer	0.000695	0.00138	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—EGFR—head and neck cancer	0.000695	0.00138	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GRP—head and neck cancer	0.000686	0.00136	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000683	0.00136	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—MAPK3—head and neck cancer	0.000675	0.00134	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT6—head and neck cancer	0.000666	0.00132	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000654	0.0013	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.000649	0.00129	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—MAPK1—head and neck cancer	0.000643	0.00128	CbGpPWpGaD
Danazol—Asthenia—Docetaxel—head and neck cancer	0.000638	0.00352	CcSEcCtD
Danazol—ESR1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000637	0.00127	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000635	0.00126	CbGpPWpGaD
Danazol—Pruritus—Docetaxel—head and neck cancer	0.000629	0.00347	CcSEcCtD
Danazol—ESR1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000628	0.00125	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GRP—head and neck cancer	0.000627	0.00125	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000622	0.00124	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000622	0.00124	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000609	0.00121	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT6—head and neck cancer	0.000609	0.00121	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000607	0.00121	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.0006	0.00119	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000598	0.00119	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000594	0.00118	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—YAP1—head and neck cancer	0.000589	0.00117	CbGpPWpGaD
Danazol—Dizziness—Docetaxel—head and neck cancer	0.000588	0.00325	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000586	0.00117	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000586	0.00117	CbGpPWpGaD
Danazol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000586	0.00117	CbGpPWpGaD
Danazol—PGR—Gene Expression—RARB—head and neck cancer	0.000574	0.00114	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—head and neck cancer	0.00057	0.00113	CbGpPWpGaD
Danazol—Vomiting—Docetaxel—head and neck cancer	0.000565	0.00312	CcSEcCtD
Danazol—Rash—Docetaxel—head and neck cancer	0.000561	0.0031	CcSEcCtD
Danazol—Dermatitis—Docetaxel—head and neck cancer	0.00056	0.00309	CcSEcCtD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000557	0.00111	CbGpPWpGaD
Danazol—Headache—Docetaxel—head and neck cancer	0.000557	0.00308	CcSEcCtD
Danazol—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000556	0.00111	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.000546	0.00109	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000545	0.00108	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.00054	0.00107	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000539	0.00107	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—YAP1—head and neck cancer	0.000539	0.00107	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000529	0.00105	CbGpPWpGaD
Danazol—Nausea—Docetaxel—head and neck cancer	0.000528	0.00292	CcSEcCtD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000526	0.00105	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000523	0.00104	CbGpPWpGaD
Danazol—PGR—Gene Expression—YAP1—head and neck cancer	0.000522	0.00104	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—HRAS—head and neck cancer	0.000516	0.00103	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	0.000516	0.00103	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—AKT1—head and neck cancer	0.000516	0.00103	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000504	0.001	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000503	0.001	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.0005	0.000993	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—AKT1—head and neck cancer	0.000493	0.000979	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000489	0.000972	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000486	0.000966	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000481	0.000957	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—KISS1—head and neck cancer	0.00048	0.000955	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000477	0.000947	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000476	0.000947	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000468	0.00093	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000456	0.000906	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—AKT1—head and neck cancer	0.000455	0.000906	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000452	0.000898	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000452	0.000898	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PTEN—head and neck cancer	0.000449	0.000893	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—AKT1—head and neck cancer	0.000441	0.000877	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000439	0.000872	CbGpPWpGaD
Danazol—AR—Gene Expression—RARB—head and neck cancer	0.000438	0.00087	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000429	0.000853	CbGpPWpGaD
Danazol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	0.000428	0.000852	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000415	0.000825	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.00041	0.000815	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.00041	0.000815	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.000408	0.000811	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.0004	0.000795	CbGpPWpGaD
Danazol—AR—Gene Expression—YAP1—head and neck cancer	0.000398	0.000791	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GRP—head and neck cancer	0.000395	0.000786	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000395	0.000785	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000395	0.000785	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000388	0.000771	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT6—head and neck cancer	0.000384	0.000763	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—MAPK3—head and neck cancer	0.000384	0.000763	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000374	0.000744	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000373	0.000741	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	0.000367	0.00073	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	0.000367	0.00073	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—MAPK1—head and neck cancer	0.000365	0.000726	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—EGFR—head and neck cancer	0.000365	0.000726	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000344	0.000684	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000343	0.000681	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.00034	0.000676	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—YAP1—head and neck cancer	0.00034	0.000675	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000338	0.000672	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000338	0.000672	CbGpPWpGaD
Danazol—ESR1—Gene Expression—RARB—head and neck cancer	0.000337	0.00067	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000337	0.000669	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000331	0.000659	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—NAT2—head and neck cancer	0.00032	0.000636	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.00032	0.000636	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000317	0.00063	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—IL2—head and neck cancer	0.000311	0.000619	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—IL2—head and neck cancer	0.000309	0.000615	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	0.000308	0.000613	CbGpPWpGaD
Danazol—ESR1—Gene Expression—YAP1—head and neck cancer	0.000307	0.00061	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000304	0.000605	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000304	0.000605	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—HRAS—head and neck cancer	0.000293	0.000583	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.000291	0.000578	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000287	0.000571	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—IL2—head and neck cancer	0.000283	0.000562	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—KISS1—head and neck cancer	0.000282	0.00056	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—DPYD—head and neck cancer	0.000281	0.000558	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.00028	0.000557	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.00027	0.000536	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—YAP1—head and neck cancer	0.000266	0.00053	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000266	0.000529	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—NOTCH1—head and neck cancer	0.000265	0.000528	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000264	0.000525	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.00026	0.000517	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—AKT1—head and neck cancer	0.000259	0.000515	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000256	0.000508	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000255	0.000508	CbGpPWpGaD
Danazol—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000252	0.000501	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK3—head and neck cancer	0.000249	0.000494	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—NOTCH1—head and neck cancer	0.000243	0.000483	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—MAPK1—head and neck cancer	0.000237	0.00047	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—head and neck cancer	0.000237	0.00047	CbGpPWpGaD
Danazol—PGR—Gene Expression—NOTCH1—head and neck cancer	0.000235	0.000468	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GRP—head and neck cancer	0.000232	0.000461	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK3—head and neck cancer	0.000227	0.000452	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT6—head and neck cancer	0.000225	0.000448	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—UROD—head and neck cancer	0.000225	0.000447	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—MAPK1—head and neck cancer	0.000216	0.00043	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—head and neck cancer	0.000216	0.00043	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000216	0.000429	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000207	0.000411	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PIK3CA—head and neck cancer	0.000205	0.000408	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.0002	0.000398	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—YAP1—head and neck cancer	0.000199	0.000396	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—HRAS—head and neck cancer	0.00019	0.000378	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PIK3CA—head and neck cancer	0.000188	0.000373	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IL2—head and neck cancer	0.000183	0.000363	CbGpPWpGaD
Danazol—AR—Gene Expression—NOTCH1—head and neck cancer	0.000179	0.000357	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CCND1—head and neck cancer	0.000178	0.000354	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000175	0.000347	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—HRAS—head and neck cancer	0.000174	0.000345	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PTEN—head and neck cancer	0.000172	0.000342	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—AKT1—head and neck cancer	0.000169	0.000336	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—AKT1—head and neck cancer	0.000168	0.000333	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IL2—head and neck cancer	0.000167	0.000332	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CCND1—head and neck cancer	0.000163	0.000324	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—TYMS—head and neck cancer	0.00016	0.000318	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GSTM1—head and neck cancer	0.000158	0.000314	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PTEN—head and neck cancer	0.000157	0.000313	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—VEGFA—head and neck cancer	0.000155	0.000309	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—STAT3—head and neck cancer	0.000154	0.000306	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—AKT1—head and neck cancer	0.000153	0.000305	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—NOTCH1—head and neck cancer	0.000153	0.000304	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GPX1—head and neck cancer	0.000151	0.000301	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—CYP1A1—head and neck cancer	0.00015	0.000298	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK3—head and neck cancer	0.000147	0.000292	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—VEGFA—head and neck cancer	0.000142	0.000282	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—STAT3—head and neck cancer	0.000141	0.00028	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MAPK1—head and neck cancer	0.00014	0.000278	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—head and neck cancer	0.00014	0.000278	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NOTCH1—head and neck cancer	0.000138	0.000275	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK3—head and neck cancer	0.000134	0.000267	CbGpPWpGaD
Danazol—PGR—Gene Expression—MAPK3—head and neck cancer	0.00013	0.000259	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MAPK1—head and neck cancer	0.000128	0.000254	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—head and neck cancer	0.000128	0.000254	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000123	0.000245	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PIK3CA—head and neck cancer	0.000121	0.000241	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—head and neck cancer	0.000117	0.000233	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—HRAS—head and neck cancer	0.000112	0.000223	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PIK3CA—head and neck cancer	0.000111	0.00022	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—head and neck cancer	0.000107	0.000213	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IL2—head and neck cancer	0.000105	0.000209	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CCND1—head and neck cancer	0.000103	0.000204	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—HRAS—head and neck cancer	0.000103	0.000204	CbGpPWpGaD
Danazol—AR—Gene Expression—MAPK3—head and neck cancer	9.93e-05	0.000197	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PTEN—head and neck cancer	9.91e-05	0.000197	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—AKT1—head and neck cancer	9.91e-05	0.000197	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—NAT2—head and neck cancer	9.34e-05	0.000186	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—AKT1—head and neck cancer	9.06e-05	0.00018	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—NOTCH1—head and neck cancer	8.99e-05	0.000179	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—VEGFA—head and neck cancer	8.95e-05	0.000178	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—head and neck cancer	8.91e-05	0.000177	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—STAT3—head and neck cancer	8.87e-05	0.000176	CbGpPWpGaD
Danazol—PGR—Gene Expression—AKT1—head and neck cancer	8.79e-05	0.000175	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK3—head and neck cancer	8.47e-05	0.000168	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—DPYD—head and neck cancer	8.19e-05	0.000163	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MAPK1—head and neck cancer	8.06e-05	0.00016	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—head and neck cancer	8.06e-05	0.00016	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—YAP1—head and neck cancer	7.77e-05	0.000155	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTEN—head and neck cancer	7.77e-05	0.000155	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MAPK3—head and neck cancer	7.65e-05	0.000152	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PIK3CA—head and neck cancer	6.99e-05	0.000139	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—head and neck cancer	6.77e-05	0.000135	CbGpPWpGaD
Danazol—AR—Gene Expression—AKT1—head and neck cancer	6.69e-05	0.000133	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—HRAS—head and neck cancer	6.47e-05	0.000129	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IL2—head and neck cancer	6.18e-05	0.000123	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CCND1—head and neck cancer	6.03e-05	0.00012	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PTEN—head and neck cancer	5.82e-05	0.000116	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—AKT1—head and neck cancer	5.71e-05	0.000114	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PIK3CA—head and neck cancer	5.48e-05	0.000109	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—VEGFA—head and neck cancer	5.26e-05	0.000104	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—STAT3—head and neck cancer	5.2e-05	0.000103	CbGpPWpGaD
Danazol—ESR1—Gene Expression—AKT1—head and neck cancer	5.16e-05	0.000103	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK3—head and neck cancer	4.97e-05	9.88e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MAPK1—head and neck cancer	4.73e-05	9.4e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—head and neck cancer	4.73e-05	9.4e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—TYMS—head and neck cancer	4.67e-05	9.28e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.61e-05	9.17e-05	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—AKT1—head and neck cancer	4.48e-05	8.91e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GPX1—head and neck cancer	4.42e-05	8.78e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.37e-05	8.7e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PIK3CA—head and neck cancer	4.1e-05	8.16e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—head and neck cancer	3.97e-05	7.89e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—HRAS—head and neck cancer	3.8e-05	7.55e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—AKT1—head and neck cancer	3.35e-05	6.67e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.6e-05	5.17e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTEN—head and neck cancer	2.27e-05	4.51e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.6e-05	3.18e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—AKT1—head and neck cancer	1.31e-05	2.6e-05	CbGpPWpGaD
